Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

Ricard Cervera, Jean Charles Piette, Josep Font, Munther A. Khamashta, Yehuda Shoenfeld, María Teresa Camps, Soren Jacobsen, Gabriella Lakos, Angela Tincani, Irene Kontopoulou-Griva, Mauro Galeazzi, Pier Luigi Meroni, Ronald H W M Derksen, Philip G. De Groot, Erika Gromnica-Ihle, Marta Baleva, Marta Mosca, Stefano Bombardieri, Frédéric Houssiau, Jean Christophe GrisIsabelle Quéré, Eric Hachulla, Carlos Vasconcelos, Beate Roch, Antonio Fernández-Nebro, Marie Claire Boffa, Graham R V Hughes, Miguel Ingelmo

Research output: Contribution to journalArticle

Abstract

Objective. To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS) in a large cohort of patients and to define patterns of disease expression. Methods. The clinical and serologic features of APS (Sapporo preliminary criteria) in 1,000 patients from 13 European countries were analyzed using a computerized database. Results. The cohort consisted of 820 female patients (82.0%) and 180 male patients (18.0%) with a mean ± SD age of 42 ± 14 years at study entry. "Primary" APS was present in 53.1% of the patients; APS was associated with systemic lupus erythematosus (SLE) in 36.2%, with lupus-like syndrome in 5.0%, and with other diseases in 5.9%. A variety of thrombotic manifestations affecting the majority of organs were recorded. A catastrophic APS occurred in 0.8% of the patients. Patients with APS associated with SLE had more episodes of arthritis and livedo reticularis, and more frequently exhibited thrombocytopenia and leukopenia. Female patients had a higher frequency of arthritis, livedo reticularis, and migraine. Male patients had a higher frequency of myocardial infarction, epilepsy, and arterial thrombosis in the lower legs and feet. In 28 patients (2.8%), disease onset occurred before age 15; these patients had more episodes of chorea and jugular vein thrombosis than the remaining patients. In 127 patients (12.7%), disease onset occurred after age 50; most of these patients were men. These patients had a higher frequency of stroke and angina pectoris, but a lower frequency of livedo reticularis, than the remaining patients. Conclusion. APS may affect any organ of the body and display a broad spectrum of manifestations. An association with SLE, the patient's sex, and the patient's age at disease onset can modify the disease expression and define specific subsets of APS.

Original languageEnglish
Pages (from-to)1019-1027
Number of pages9
JournalArthritis and Rheumatism
Volume46
Issue number4
DOIs
Publication statusPublished - 2002

Fingerprint

Antiphospholipid Syndrome
Livedo Reticularis
Systemic Lupus Erythematosus
Arthritis
Thrombosis
Chorea
Jugular Veins
Leukopenia
Angina Pectoris

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Cervera, R., Piette, J. C., Font, J., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., ... Ingelmo, M. (2002). Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis and Rheumatism, 46(4), 1019-1027. https://doi.org/10.1002/art.10187

Antiphospholipid syndrome : Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. / Cervera, Ricard; Piette, Jean Charles; Font, Josep; Khamashta, Munther A.; Shoenfeld, Yehuda; Camps, María Teresa; Jacobsen, Soren; Lakos, Gabriella; Tincani, Angela; Kontopoulou-Griva, Irene; Galeazzi, Mauro; Meroni, Pier Luigi; Derksen, Ronald H W M; De Groot, Philip G.; Gromnica-Ihle, Erika; Baleva, Marta; Mosca, Marta; Bombardieri, Stefano; Houssiau, Frédéric; Gris, Jean Christophe; Quéré, Isabelle; Hachulla, Eric; Vasconcelos, Carlos; Roch, Beate; Fernández-Nebro, Antonio; Boffa, Marie Claire; Hughes, Graham R V; Ingelmo, Miguel.

In: Arthritis and Rheumatism, Vol. 46, No. 4, 2002, p. 1019-1027.

Research output: Contribution to journalArticle

Cervera, R, Piette, JC, Font, J, Khamashta, MA, Shoenfeld, Y, Camps, MT, Jacobsen, S, Lakos, G, Tincani, A, Kontopoulou-Griva, I, Galeazzi, M, Meroni, PL, Derksen, RHWM, De Groot, PG, Gromnica-Ihle, E, Baleva, M, Mosca, M, Bombardieri, S, Houssiau, F, Gris, JC, Quéré, I, Hachulla, E, Vasconcelos, C, Roch, B, Fernández-Nebro, A, Boffa, MC, Hughes, GRV & Ingelmo, M 2002, 'Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients', Arthritis and Rheumatism, vol. 46, no. 4, pp. 1019-1027. https://doi.org/10.1002/art.10187
Cervera, Ricard ; Piette, Jean Charles ; Font, Josep ; Khamashta, Munther A. ; Shoenfeld, Yehuda ; Camps, María Teresa ; Jacobsen, Soren ; Lakos, Gabriella ; Tincani, Angela ; Kontopoulou-Griva, Irene ; Galeazzi, Mauro ; Meroni, Pier Luigi ; Derksen, Ronald H W M ; De Groot, Philip G. ; Gromnica-Ihle, Erika ; Baleva, Marta ; Mosca, Marta ; Bombardieri, Stefano ; Houssiau, Frédéric ; Gris, Jean Christophe ; Quéré, Isabelle ; Hachulla, Eric ; Vasconcelos, Carlos ; Roch, Beate ; Fernández-Nebro, Antonio ; Boffa, Marie Claire ; Hughes, Graham R V ; Ingelmo, Miguel. / Antiphospholipid syndrome : Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. In: Arthritis and Rheumatism. 2002 ; Vol. 46, No. 4. pp. 1019-1027.
@article{25d9eae298d34028aae11303d07d244a,
title = "Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients",
abstract = "Objective. To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS) in a large cohort of patients and to define patterns of disease expression. Methods. The clinical and serologic features of APS (Sapporo preliminary criteria) in 1,000 patients from 13 European countries were analyzed using a computerized database. Results. The cohort consisted of 820 female patients (82.0{\%}) and 180 male patients (18.0{\%}) with a mean ± SD age of 42 ± 14 years at study entry. {"}Primary{"} APS was present in 53.1{\%} of the patients; APS was associated with systemic lupus erythematosus (SLE) in 36.2{\%}, with lupus-like syndrome in 5.0{\%}, and with other diseases in 5.9{\%}. A variety of thrombotic manifestations affecting the majority of organs were recorded. A catastrophic APS occurred in 0.8{\%} of the patients. Patients with APS associated with SLE had more episodes of arthritis and livedo reticularis, and more frequently exhibited thrombocytopenia and leukopenia. Female patients had a higher frequency of arthritis, livedo reticularis, and migraine. Male patients had a higher frequency of myocardial infarction, epilepsy, and arterial thrombosis in the lower legs and feet. In 28 patients (2.8{\%}), disease onset occurred before age 15; these patients had more episodes of chorea and jugular vein thrombosis than the remaining patients. In 127 patients (12.7{\%}), disease onset occurred after age 50; most of these patients were men. These patients had a higher frequency of stroke and angina pectoris, but a lower frequency of livedo reticularis, than the remaining patients. Conclusion. APS may affect any organ of the body and display a broad spectrum of manifestations. An association with SLE, the patient's sex, and the patient's age at disease onset can modify the disease expression and define specific subsets of APS.",
author = "Ricard Cervera and Piette, {Jean Charles} and Josep Font and Khamashta, {Munther A.} and Yehuda Shoenfeld and Camps, {Mar{\'i}a Teresa} and Soren Jacobsen and Gabriella Lakos and Angela Tincani and Irene Kontopoulou-Griva and Mauro Galeazzi and Meroni, {Pier Luigi} and Derksen, {Ronald H W M} and {De Groot}, {Philip G.} and Erika Gromnica-Ihle and Marta Baleva and Marta Mosca and Stefano Bombardieri and Fr{\'e}d{\'e}ric Houssiau and Gris, {Jean Christophe} and Isabelle Qu{\'e}r{\'e} and Eric Hachulla and Carlos Vasconcelos and Beate Roch and Antonio Fern{\'a}ndez-Nebro and Boffa, {Marie Claire} and Hughes, {Graham R V} and Miguel Ingelmo",
year = "2002",
doi = "10.1002/art.10187",
language = "English",
volume = "46",
pages = "1019--1027",
journal = "Arthritis care and research : the official journal of the Arthritis Health Professions Association",
issn = "0893-7524",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Antiphospholipid syndrome

T2 - Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

AU - Cervera, Ricard

AU - Piette, Jean Charles

AU - Font, Josep

AU - Khamashta, Munther A.

AU - Shoenfeld, Yehuda

AU - Camps, María Teresa

AU - Jacobsen, Soren

AU - Lakos, Gabriella

AU - Tincani, Angela

AU - Kontopoulou-Griva, Irene

AU - Galeazzi, Mauro

AU - Meroni, Pier Luigi

AU - Derksen, Ronald H W M

AU - De Groot, Philip G.

AU - Gromnica-Ihle, Erika

AU - Baleva, Marta

AU - Mosca, Marta

AU - Bombardieri, Stefano

AU - Houssiau, Frédéric

AU - Gris, Jean Christophe

AU - Quéré, Isabelle

AU - Hachulla, Eric

AU - Vasconcelos, Carlos

AU - Roch, Beate

AU - Fernández-Nebro, Antonio

AU - Boffa, Marie Claire

AU - Hughes, Graham R V

AU - Ingelmo, Miguel

PY - 2002

Y1 - 2002

N2 - Objective. To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS) in a large cohort of patients and to define patterns of disease expression. Methods. The clinical and serologic features of APS (Sapporo preliminary criteria) in 1,000 patients from 13 European countries were analyzed using a computerized database. Results. The cohort consisted of 820 female patients (82.0%) and 180 male patients (18.0%) with a mean ± SD age of 42 ± 14 years at study entry. "Primary" APS was present in 53.1% of the patients; APS was associated with systemic lupus erythematosus (SLE) in 36.2%, with lupus-like syndrome in 5.0%, and with other diseases in 5.9%. A variety of thrombotic manifestations affecting the majority of organs were recorded. A catastrophic APS occurred in 0.8% of the patients. Patients with APS associated with SLE had more episodes of arthritis and livedo reticularis, and more frequently exhibited thrombocytopenia and leukopenia. Female patients had a higher frequency of arthritis, livedo reticularis, and migraine. Male patients had a higher frequency of myocardial infarction, epilepsy, and arterial thrombosis in the lower legs and feet. In 28 patients (2.8%), disease onset occurred before age 15; these patients had more episodes of chorea and jugular vein thrombosis than the remaining patients. In 127 patients (12.7%), disease onset occurred after age 50; most of these patients were men. These patients had a higher frequency of stroke and angina pectoris, but a lower frequency of livedo reticularis, than the remaining patients. Conclusion. APS may affect any organ of the body and display a broad spectrum of manifestations. An association with SLE, the patient's sex, and the patient's age at disease onset can modify the disease expression and define specific subsets of APS.

AB - Objective. To analyze the clinical and immunologic manifestations of antiphospholipid syndrome (APS) in a large cohort of patients and to define patterns of disease expression. Methods. The clinical and serologic features of APS (Sapporo preliminary criteria) in 1,000 patients from 13 European countries were analyzed using a computerized database. Results. The cohort consisted of 820 female patients (82.0%) and 180 male patients (18.0%) with a mean ± SD age of 42 ± 14 years at study entry. "Primary" APS was present in 53.1% of the patients; APS was associated with systemic lupus erythematosus (SLE) in 36.2%, with lupus-like syndrome in 5.0%, and with other diseases in 5.9%. A variety of thrombotic manifestations affecting the majority of organs were recorded. A catastrophic APS occurred in 0.8% of the patients. Patients with APS associated with SLE had more episodes of arthritis and livedo reticularis, and more frequently exhibited thrombocytopenia and leukopenia. Female patients had a higher frequency of arthritis, livedo reticularis, and migraine. Male patients had a higher frequency of myocardial infarction, epilepsy, and arterial thrombosis in the lower legs and feet. In 28 patients (2.8%), disease onset occurred before age 15; these patients had more episodes of chorea and jugular vein thrombosis than the remaining patients. In 127 patients (12.7%), disease onset occurred after age 50; most of these patients were men. These patients had a higher frequency of stroke and angina pectoris, but a lower frequency of livedo reticularis, than the remaining patients. Conclusion. APS may affect any organ of the body and display a broad spectrum of manifestations. An association with SLE, the patient's sex, and the patient's age at disease onset can modify the disease expression and define specific subsets of APS.

UR - http://www.scopus.com/inward/record.url?scp=0036228886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036228886&partnerID=8YFLogxK

U2 - 10.1002/art.10187

DO - 10.1002/art.10187

M3 - Article

C2 - 11953980

AN - SCOPUS:0036228886

VL - 46

SP - 1019

EP - 1027

JO - Arthritis care and research : the official journal of the Arthritis Health Professions Association

JF - Arthritis care and research : the official journal of the Arthritis Health Professions Association

SN - 0893-7524

IS - 4

ER -